What NOCIL Doubters Saw Before The Drop
NOCIL posted higher quarterly revenue and profit by Q1 2027, yet long-term holders still saw their capital shrink. For NOCIL shareholders, the loss over the past year was 21.2%, including dividends. If you had committed new money in October 2025, trusting bullish export stories or wary of Chinese dumping, you now face a simple question: What in the original filings and competing analyst views hinted that better results might still pair with a falling share price?
NOCIL has already moved. See which of 199 high quality undervalued stocks still trade below our estimates.
The Two NOCIL Stories Investors Were Weighing
The shares cost ₹182 at the start of the period, and anyone buying NOCIL then had to choose between two very different but reasonable stories.
The bullish camp saw the Dahej expansion and protective trade actions as a springboard. They treated a Fair Value of ₹218, implying what they believed the business could be worth if their export and margin assumptions played out, as justified by antidumping support and higher utilization.
The bearish side anchored on a Fair Value of ₹168. They worried that Chinese dumping, weak demand in Europe and the US, and EV driven shifts in tire use could pressure margins and leave those capacity additions underused.
What The Results Changed For The NOCIL Debate
The clearest proof point was NOCIL’s Q1 2027 set of numbers. Revenue moved from ₹3,362.2m in Q1 2026 to ₹4,030.2m in Q1 2027, while net income rose from ₹172.6m to ₹277.6m and net margin lifted from 5.1% to 6.9%. That combination supported the bullish idea of better utilization and profitability, although only over a single quarter.
The useful takeaway is simple. When a thesis depends on margin improvement, do not just watch sales. Track net margin alongside revenue and profit in each filing, then ask whether the direction lines up with the original claim.
What You Would Be Paying For In NOCIL Today
NOCIL now trades at ₹147, with the stock down 21.2% over the past year. The selected Narrative places its Fair Value above this level, based on a view that current duties, export plans and specialty products can reshape how earnings power looks over the next few years.
A buyer today would need to judge whether sustained trade protection and a richer export and specialty mix can outweigh dumping pressure and softer overseas rubber demand enough for that Narrative to hold.
"Ongoing anti dumping duties on key rubber chemicals, including the recent approval on sulphenamides CBS and NS that together with other covered products represent a sizeable share of NOCIL’s revenue, can limit price pressure from imports and support higher domestic EBITDA margins."
That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for
Before The Next Story Makes Headlines
Passing on this one could have spared you a loss. Where might you find the opposite surprise? Start looking for companies whose prices leave room for a better outcome than investors expect. These three trade below our estimated value.
- Company 1 - 30% below our estimate - expands higher margin B2B and video collaboration hardware tied to internal AI tools.
- Company 2 - 42% below our estimate - wins more recurring contracts as new digital forensics platforms handle rising mobile evidence complexity.
- Company 3 - 24% below our estimate - grows maintenance and modernization base by enlarging its salesforce to convert more service contracts.
Those are three of them. See every one of the 204 solid balance sheet companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com